SANUWAVE Health, Inc. (SNWV)
OTCMKTS
· Delayed Price · Currency is USD
21.00
-1.50 (-6.67%)
Dec 31, 2024, 2:46 PM EST
SANUWAVE Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 29.3 | 20.4 | 16.74 | 13.01 | 4.06 | 1.03 | Upgrade
|
| Revenue | 29.3 | 20.4 | 16.74 | 13.01 | 4.06 | 1.03 | Upgrade
|
| Revenue Growth (YoY) | 55.00% | 21.84% | 28.69% | 220.68% | 294.37% | -44.39% | Upgrade
|
| Cost of Revenue | 7.96 | 6.04 | 4.33 | 4.99 | 1.16 | 0.54 | Upgrade
|
| Gross Profit | 21.34 | 14.36 | 12.41 | 8.02 | 2.9 | 0.49 | Upgrade
|
| Selling, General & Admin | 15.99 | 13.57 | 20.03 | 20.28 | 17.78 | 8.03 | Upgrade
|
| Research & Development | 0.66 | 0.58 | 0.57 | 1.1 | 1.25 | 1.18 | Upgrade
|
| Operating Expenses | 17.41 | 14.9 | 21.36 | 22.17 | 19.81 | 9.28 | Upgrade
|
| Operating Income | 3.93 | -0.54 | -8.95 | -14.14 | -16.92 | -8.79 | Upgrade
|
| Interest Expense | -14.12 | -15.62 | -14.13 | -7.1 | -2.54 | -1.84 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0 | -0.04 | -0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.6 | -9.64 | 16.65 | -2.62 | -2.59 | 0.23 | Upgrade
|
| EBT Excluding Unusual Items | -5.59 | -25.8 | -6.44 | -23.86 | -22.09 | -10.43 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -1.1 | - | Upgrade
|
| Asset Writedown | - | - | - | - | -7.19 | - | Upgrade
|
| Other Unusual Items | 5.21 | - | -3.85 | -3.37 | -0.57 | - | Upgrade
|
| Pretax Income | -0.39 | -25.8 | -10.29 | -27.23 | -30.94 | -10.43 | Upgrade
|
| Income Tax Expense | 0 | 0 | 0 | 0.03 | - | - | Upgrade
|
| Earnings From Continuing Operations | -0.39 | -25.81 | -10.29 | -27.26 | -30.94 | -10.43 | Upgrade
|
| Net Income | -0.39 | -25.81 | -10.29 | -27.26 | -30.94 | -10.43 | Upgrade
|
| Net Income to Common | -0.39 | -25.81 | -10.29 | -27.26 | -30.94 | -10.43 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 2 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 2 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 77.92% | 44.48% | 6.00% | 37.08% | 85.73% | 36.14% | Upgrade
|
| EPS (Basic) | -0.13 | -12.19 | -7.02 | -19.72 | -30.68 | -19.21 | Upgrade
|
| EPS (Diluted) | -0.13 | -12.19 | -7.50 | -19.72 | -30.68 | -19.21 | Upgrade
|
| Free Cash Flow | 0.34 | -4.54 | -17.17 | -6.94 | -12.77 | -6.46 | Upgrade
|
| Free Cash Flow Per Share | 0.11 | -2.14 | -11.72 | -5.02 | -12.67 | -11.91 | Upgrade
|
| Gross Margin | 72.84% | 70.41% | 74.13% | 61.68% | 71.36% | 47.61% | Upgrade
|
| Operating Margin | 13.43% | -2.65% | -53.47% | -108.70% | -416.93% | -854.87% | Upgrade
|
| Profit Margin | -1.33% | -126.52% | -61.48% | -209.52% | -762.56% | -1013.86% | Upgrade
|
| Free Cash Flow Margin | 1.17% | -22.25% | -102.55% | -53.33% | -314.79% | -628.42% | Upgrade
|
| EBITDA | 4.92 | 0.49 | -8 | -12.91 | -15.9 | -8.72 | Upgrade
|
| EBITDA Margin | 16.78% | 2.39% | -47.78% | -99.20% | - | - | Upgrade
|
| D&A For EBITDA | 0.98 | 1.03 | 0.95 | 1.24 | 1.01 | 0.07 | Upgrade
|
| EBIT | 3.93 | -0.54 | -8.95 | -14.14 | -16.92 | -8.79 | Upgrade
|
| EBIT Margin | 13.43% | -2.65% | -53.47% | -108.70% | - | - | Upgrade
|
| Revenue as Reported | - | - | - | - | 4.06 | 1.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.